847 phase II study of the mitochondrial antioxidant mitoquinone for hepatitis C
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MitoQ has been tested successfully in human diseases such as Hepatitis C induced liver disease and skin photo damage and in experimental animal models including ischemia-reperfusion, neurodegenerative diseases, diabetes, and alcohol-induced hepatosteatosis.
“For example, Mitoquinone (MitoQ) has been tested successfully in human diseases such as Hepatitis C induced liver disease and skin photo damage as well as a number of experimental animal models including ischemia-reperfusion, neurodegenerative diseases, diabetes, and alcohol-induced hepatosteatosis [8–14].”
From Mitochondrially targeted compounds and their impact on cellular bioenergetics (2013) · cites this paper as [8]
Cited by
Sorted by citations
Mitochondrially targeted compounds and their impact on cellular bioenergetics
Reily, C., Mitchell, T., Chacko, B. K., Benavides, G. A., Murphy, M. P., & Darley-Usmar, V. M. (2013) · Redox Biology · doi:10.1016/j.redox.2012.11.009 · Cited by 227 · see citing works
Self-citation
- Authors
- Gane, E. J., Orr, D. W., Weilert, F., Keogh, G. F., Gibson, M., Murphy, M. P., Smith, R. A., Lockhart, M. M., Frampton, C. M., & Taylor, K. M.
- Affiliations
- Auckland City Hospital (NZ)
- Waikato Hospital (NZ)
- Shupyk National Healthcare University of Ukraine (UA)
- National Pirogov Memorial Medical University, Vinnytsya (UA)
- University of Otago (NZ)
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 48
- Pages
- S318
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W1998573071
- Cited by
- 11
- References
- 0
- Citations by year
- 2015: 1 · 2014: 1 · 2013: 1
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hepatology (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- mitochondrial antioxidants, hepatitis C, oxidative stress, mitochondrial damage, apoptosis, serum ALT, transaminases, HCV RNA, necroinflammation, coenzyme Q10, triphenylphosphonium cation, interferon-naive patients, drug safety and tolerability, antiviral therapy, liver enzymes, fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
